1. Home
  2. OSS vs NTHI Comparison

OSS vs NTHI Comparison

Compare OSS & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Stop Systems Inc.

OSS

One Stop Systems Inc.

HOLD

Current Price

$9.45

Market Cap

197.3M

Sector

Technology

ML Signal

HOLD

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$11.08

Market Cap

221.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSS
NTHI
Founded
1998
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.3M
221.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
OSS
NTHI
Price
$9.45
$11.08
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
3.1M
71.2K
Earning Date
03-18-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,264,017.00
$59,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.33
N/A
52 Week Low
$1.85
$3.20
52 Week High
$12.75
$25.00

Technical Indicators

Market Signals
Indicator
OSS
NTHI
Relative Strength Index (RSI) 50.60 64.35
Support Level $7.96 $9.05
Resistance Level $11.09 $11.31
Average True Range (ATR) 0.90 1.15
MACD -0.22 0.17
Stochastic Oscillator 43.71 80.93

Price Performance

Historical Comparison
OSS
NTHI

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: